jain.com

At Market Offering agreement for ordinary shares

Company: IREN

Subject kind
financing
Statement date
2023-09-25
Promised amount
300000000.0 USD
Event date
2023-09-13
Current status
stated

What the later record shows

Not a promise: a reported event · happened September 13, 2023

The claim reports an At Market Issuance Sales Agreement already entered into, dated September 13, 2023. No passage discusses this agreement further.

Checked October 9, 2026 against filings, releases and reporting published after the claim was made. Quotes are verbatim from the linked documents.

The claim, verbatim

Entered into At Market Issuance Sales Agreement with B. Riley, Cantor Fitzgerald, and Compass Point for up to $300,000,000 in ordinary shares dated September 13, 2023

Source (primary)

IREN 424B3 filed 2023-09-26 (SEC EDGAR, sec_filing)
View cached copy (2026-09-13)Live source ↗

Quote: “We have entered into an At Market Issuance Sales Agreement with B. Riley Securities, Inc. ("B. Riley"), Cantor Fitzgerald & Co. ("Cantor") and Compass Point Research & Trading, LLC ("Compass Point")... under this prospectus supplement, we may offer and sell our ordinary shares having an aggregate offering price of up to $300,000,000”

How we checked this

Checked on October 11, 2026. The cited source supports every part of this claim.

The prospectus supplement's cover page names all three sales agents and the $300,000,000 maximum, and dates the sales agreement September 13, 2023.

Confirmed in the source:

What we did: Read our cached copy of SEC EDGAR (https://www.sec.gov/Archives/edgar/data/1878848/000114036123045182/ny20011264x1_424b3.htm) in full (233,579 characters, retrieved September 13, 2026) and checked each assertion in the claim against it.

Additional evidence

confirms IREN 424B3 filed 2023-09-26

Quote: “We have entered into an At Market Issuance Sales Agreement with B. Riley Securities, Inc. ("B. Riley"), Cantor Fitzgerald & Co. ("Cantor") and Compass Point Research & Trading, LLC ("Compass Point")... under this prospectus supplement, we may offer and sell our ordinary shares having an aggregate offering price of up to $300,000,000”

View cached copy (2026-09-13)Live source ↗

Record of changes

September 13, 2026 — stated
Automated extraction from the cited source. Recorded automatically from the cited source when it was published, then queued for evidence review.
September 14, 2026 — delayed
Automated extraction from the cited source. Recorded automatically from the cited source when it was published, then queued for evidence review.
October 9, 2026 — outcome unconfirmed
Automated extraction from the cited source. Recorded automatically from the cited source when it was published, then queued for evidence review.
October 9, 2026 — stated
Automated extraction from the cited source. Recorded automatically from the cited source when it was published, then queued for evidence review.